Perioperative management of antiplatelet-drugs in cardiac surgery

Area of Science:

• Cardiology
• Vascular Surgery
• Pharmacology

Background:

• Management of coronary artery bypass grafting (CABG) patients on antiplatelet therapy presents significant clinical challenges.
• Antiplatelet drug withdrawal increases thrombotic event risk, while continuing them raises perioperative bleeding concerns.

Purpose of the Study:

• To review and evaluate the outcomes of various perioperative antiplatelet strategies in patients with coronary artery disease undergoing CABG.
• To address the conflicting recommendations regarding antiplatelet management in this patient population.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies comparing different antiplatelet drug withdrawal and continuation protocols.
• Evaluation of associated thrombotic and bleeding complications.

Main Results:

• Data synthesis on the comparative efficacy and safety of different antiplatelet management strategies.
• Identification of protocols associated with lower rates of thrombotic events and perioperative bleeding.
• Assessment of the impact of specific antiplatelet agents on surgical outcomes.

Conclusions:

• Evidence-based recommendations for optimizing perioperative antiplatelet management in CABG patients.
• Guidance on balancing the risks of thrombosis and bleeding in this high-risk group.
• Informing clinical decision-making for cardiologists and cardiac surgeons.